8-K

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): December 11, 2006

Rochester Medical Corporation
__________________________________________
(Exact name of registrant as specified in its charter)

Minnesota	0-18933	41-1613227
_____________________ (State or other jurisdiction	_____________ (Commission	______________ (I.R.S. Employer
of incorporation)	File Number)	Identification No.)
One Rochester Medical Drive, Stewartville, Minnesota		55976
_________________________________ (Address of principal executive offices)		___________ (Zip Code)

Registrant’s telephone number, including area code: 507-533-9600

Not Applicable
______________________________________________
Former name or former address, if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01 Other Events.

On December 11, 2006, Rochester Medical Corporation announced it had entered into a new Private Label arrangement and signed related agreements with Hollister Incorporated. A copy of the press release that discusses these matters is filed as Exhibit 99.1 to, and incorporated by reference in, this report.

Item 9.01 Financial Statements and Exhibits.

99.1 Press release dated December 11, 2006.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Rochester Medical Corporation
December 12, 2006	By:	/s/ David A. Jonas
		Name: David A. Jonas
		Title: Chief Financial Officer

Exhibit Index

Exhibit No.	Description
99.1	Press Release dated 12-11-2006

EX-99.1

FOR RELEASE
3:00 p.m., C.S.T
December 11, 2006

Rochester Medical Announces Agreements With Hollister Incorporated

Stewartville, MN December 11, 2006

Rochester Medical Corporation (NASADQ: ROCM) today announced that it has signed a new Private Label Agreement for supply of Male External Catheters (MECs) to Hollister Incorporated and also announced that the parties have amended their 2003 OEM/Private Label Agreement.

The MEC Agreement has a five year term commencing on January 1, 2007. Under the Agreement Rochester Medical will continue to supply Hollister with its requirements of non-latex Male External Catheters for sale under the Hollister brand worldwide, excluding the United Kingdom.

Under the amended 2003 OEM/Private Label Agreement Rochester Medical will continue to supply Hollister with Hydrophilic Intermittent catheters which will be sold under Hollister’s brand. The amended agreement has a two year term.

The two companies have also agreed to terminate the Common Interest and Defense Agreement which they entered into in September, 2004 for the defense of Rochester Medical’s Hydrophilic Intermittent catheter technology with respect to the patent infringement action in the United Kingdom between Coloplast A/S and Hollister. Hollister and Rochester Medical have agreed to release each other from any claims under the Common Interest and Defense Agreement. In particular, Rochester Medical will not be required to pay any additional legal fees under the terminated Agreement.

Commenting on the announcement, Rochester Medical CEO and President Anthony J. Conway said, “I am very pleased to make this announcement. Hollister has been an excellent customer of Rochester Medical since 1994, and we look forward to a continued strong relationship.”

Rochester Medical Corporation develops, manufactures, and markets disposable medical catheters and devices for urological and continence care applications worldwide. The Company markets under its own Rochester Medical^® brand and under existing private label arrangements.

Hollister Incorporated is an independently owned global company that develops, manufactures, and markets healthcare products in over 90 countries.

For further information, please contact Anthony J. Conway, President and Chief Executive Officer of Rochester Medical Corporation at (507) 533-9600. More information about Rochester Medical is available on its website at http://www.rocm.com.